Understanding the Critical Role of Lupus Clinical Trial Outcome Measures in Advancing Therapeutic Development

Join Dr. Anna Wolska from the Lupus Foundation of America and Dr. Laurent Arnaud, Professor of Rheumatology at the Department of Rheumatology, University Hospitals of Strasbourg as they discuss systemic lupus erythematosus (SLE) clinical trials. In this episode, Dr. Arnaud highlights the complexities of drug approval processes in lupus, the pivotal role of large-scale phase three randomized trials and critical outcome measures in these trials, from primary endpoints assessing treatment efficacy to secondary and exploratory measures capturing broader impacts on patient health and quality of life. Read the article:

You can listen to Understanding the Critical Role of Lupus Clinical Trial Outcome Measures in Advancing Therapeutic Development online on Radio and Podcast. Open the player on this page to stream the available audio.

Understanding the Critical Role of Lupus Clinical Trial Outcome Measures in Advancing Therapeutic Development is an episode from Lupus Science and Medicine podcast by BMJ Group.

This episode is 19:43 long.

This episode was published on Jul 1, 2024.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Lupus Science and Medicine podcast when more episodes are available from the podcast feed.